Virinchi Limited has informed the Exchange regarding Outcome of Board Meeting held on August 22, 2025.
VIRINCHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Virinchi Limited's board has approved the transfer of its entire SaaS (Software as a Service) business to a newly incorporated wholly owned subsidiary (NewCo) on a slump sale basis, effective April 1, 2025. The company plans to list NewCo via an IPO shortly after the transfer, structured as a combination of an Offer for Sale by Virinchi and a Fresh Issue by NewCo, with Arihant Capital Markets appointed as the merchant banker. Proceeds from the OFS will be used by Virinchi to reduce parent-level debt and invest in its healthcare vertical, while NewCo's fresh issue proceeds will fund organic SaaS growth and potential acquisitions. A valuation report is expected in 30–45 days, after which the Business Transfer Agreement will be executed. The board also approved the re-appointment of two directors and scheduled the 36th AGM for September 30, 2025.
Existing Virinchi shareholders retain 100% economic interest in the SaaS business through the new subsidiary, so no value is being given away—the real upside will depend on the eventual IPO valuation of NewCo. In the short term, the announcement could lift sentiment due to IPO optionality and planned debt reduction, but clarity on NewCo's market valuation will only emerge at the pre-IPO placement or IPO stage.